Study of Bitopertin in Participants With EPP or XLP (APOLLO)

Clinical trial NCT06910358 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06910358
Sponsor: Disc Medicine, Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Erythropoietic Protoporphyria (EPP)X-Linked Protoporphyria (XLP)

Start date: 2025-04-04
Primary completion: 2026-09-01
Enrollment: 183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.